Oncogene - Table of Contents alert Volume 35 Issue 40

If you are unable to see the message below, click here to view.

Advertisement First antibodies for Cpf1 available at Diagenode! We offer the antibodies for the most promising Cpf1 gene editing candidates: L. bacterium CRISPR/Cpf1 polyclonal antibody — validated in IF, IP, Western blot Acidaminococcus sp. CRISPR/Cpf1 polyclonal antibody — ideal for Western blot Learn more. TABLE OF CONTENTS Volume 35, Issue 40 (October 2016) In this issue Review Original Articles Also new AOP Advertisement nature.com webcasts Springer Nature presents a custom webcast on: Reveal hidden genetic variation by combining long-read target capture with SMRT Sequencing Date: Thursday October 13, 2016 Time: 8AM PDT, 11AM EDT, 4PM BST, 5PM CEST Register for FREE Sponsored by: PacBio Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Cell Death & Disease is an online-only, open access journal seeking to promote diverse and integrated areas of experimental and internal medicine with its specialities, including cancer, cancer metabolism, immunity and neuroscience. Explore the benefits of submitting your next research article. Review Top The molecular mechanics of mixed lineage leukemia R K Slany Oncogene 2016 35: 5215-5223; advance online publication, February 29, 2016; 10.1038/onc.2016.30 Abstract | Full Text Original Articles Top Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen α1(VI) I García-Palmero, S Torres, R A Bartolomé, A Peláez-García, M J Larriba, M Lopez-Lucendo, C Peña, B Escudero-Paniagua, A Muñoz and J I Casal Oncogene 2016 35: 5224-5236; advance online publication, March 14, 2016; 10.1038/onc.2016.57 Abstract | Full Text Olfactomedin 4 deletion induces colon adenocarcinoma in ApcMin/+ mice OPEN W Liu, H Li, S-H Hong, G P Piszczek, W Chen and G P Rodgers Oncogene 2016 35: 5237-5247; advance online publication, March 14, 2016; 10.1038/onc.2016.58 Abstract | Full Text Cancer stem cell drugs target K-ras signaling in a stemness context OPEN A K Najumudeen, A Jaiswal, B Lectez, C Oetken-Lindholm, C Guzmán, E Siljamäki, I M D Posada, E Lacey, T Aittokallio and D Abankwa Oncogene 2016 35: 5248-5262; advance online publication, March 14, 2016; 10.1038/onc.2016.59 Abstract | Full Text Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion T T Vellinga, S den Uil, I H B Rinkes, D Marvin, B Ponsioen, A Alvarez-Varela, S Fatrai, C Scheele, D A Zwijnenburg, H Snippert, L Vermeulen, J P Medema, H B Stockmann, J Koster, R J A Fijneman, J de Rooij and O Kranenburg Oncogene 2016 35: 5263-5271; advance online publication, March 21, 2016; 10.1038/onc.2016.60 Abstract | Full Text The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia C O'Connor, F Lohan, J Campos, E Ohlsson, M Salomè, C Forde, R Artschwager, R M Liskamp, M R Cahill, P A Kiely, B Porse and K Keeshan Oncogene 2016 35: 5272-5281; advance online publication, March 21, 2016; 10.1038/onc.2016.66 Abstract | Full Text Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death S Bhattacharya, A M Chalk, A J M Ng, T J Martin, A C Zannettino, L E Purton, J Lu, E K Baker and C R Walkley Oncogene 2016 35: 5282-5294; advance online publication, April 4, 2016; 10.1038/onc.2016.68 Abstract | Full Text AMPK promotes tolerance to Ras pathway inhibition by activating autophagy S Sanduja, Y Feng, R A Mathis, E S Sokol, F Reinhardt, R Halaban and P B Gupta Oncogene 2016 35: 5295-5303; advance online publication, April 4, 2016; 10.1038/onc.2016.70 Abstract | Full Text The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma T Muramatsu, K-i Kozaki, S Imoto, R Yamaguchi, H Tsuda, T Kawano, N Fujiwara, M Morishita, S Miyano and J Inazawa Oncogene 2016 35: 5304-5316; advance online publication, April 4, 2016; 10.1038/onc.2016.71 Abstract | Full Text CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor OPEN S Nodomi, K Umeda, S Saida, T Kinehara, T Hamabata, T Daifu, I Kato, H Hiramatsu, K-i Watanabe, Y Kuwahara, T Iehara, S Adachi, E Konishi, T Nakahata, H Hosoi and T Heike Oncogene 2016 35: 5317-5327; advance online publication, April 4, 2016; 10.1038/onc.2016.72 Abstract | Full Text An ultra-deep sequencing strategy to detect sub-clonal TP53 mutations in presentation chronic lymphocytic leukaemia cases using multiple polymerases L Worrillow, P Baskaran, M A Care, A Varghese, T Munir, P A Evans, S J O'Connor, A Rawstron, L Hazelwood, R M Tooze, P Hillmen and D J Newton Oncogene 2016 35: 5328-5336; advance online publication, April 4, 2016; 10.1038/onc.2016.73 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.